arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Lifeward Ltd.

LFWD
$5.94 ▼ -0.02 (-0.34%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
50 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Lifeward Ltd. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $16.6M
Dividend Yield —
Revenue Growth 15.7% ↗
Op. Margin -62.7% ↗
ROIC -34.0% ↗
FCF / Share $-2.15 ↗
Trailing P/E —
Price / Book 1.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

50-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$6.62M
↑ +15.7% —
Net Income Profit after all expenses
$-11.52M
↓ -75.5% —
Operating Margin Operating profit as % of sales
-62.7%
↑ +76.2% 3th
FCF / Share Free cash flow per share
$-2.15
↑ +5.7% —
Long-Term Debt Long-term obligations
$394.00K
↑ +0.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
3
Returns ↓
1
Financial Health ↑
16
Cash Quality ↓
57

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 15 years · 50 quarters